THE NATIONAL CONSENSUS PROJECT* «CYSTIC FIBROSIS: DEFINITION, DIAGNOSTIC CRITERIA, AND THERAPY». SECTION «INHALATION THERAPY» (ABRIDGED)

The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including glucocorticoids, recommended for use in cystic fibrosis...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Ye. L. Amelina, I. K. Asherova, I. K. Volkov, Т. Ye. Gembitskaya, Ye. K. Ginter, N. А. Il’yenkova, N. I. Kapranov, I. P. Karimova, N. Yu. Kashirskaya, Ye. I. Kondrat’yeva, М. N. Kostyleva, S. А. Krasovsky, N. B. Merzlova, L. P. Nazarenko, L. S. Namazova-Baranova, А. F. Neretina, V. S. Nikonova, А. V. Orlov, S. S. Postnikov, Т. А. Protasova, S. Yu. Semykin, D. F. Sergienko, О. I. Simonova, I. D. Uspenskaya, М. Yu. Chernukha, L. А. Shabalova, I. А. Shaginyan, V. D. Sherman
Format:	Artigo
Sprog:	Inglês
Udgivet:	"Paediatrician" Publishers LLC 2014-12-01
Serier:	Вопросы современной педиатрии
Fag:	cystic fibrosis inhalation therapy bronchodilators mucolytics dornase alfa hypertonic saline glucocorticoids
Online adgang:	https://vsp.spr-journal.ru/jour/article/view/109
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!